L. Browne

L. Browne

Directeur Général chez
Rythera Therapeutics, Inc.

Fortune : 817 992 $ au 30/06/2026

65 ans
Health Technology
Commercial Services
Consumer Services

Profil

L.
Daniel Browne
was the founder of Revance Therapeutics, Inc., founded in 1999, where the titles held included President, Chief Executive Officer & Director from 2014 to 2019.
Mr. Browne was the founder of Avava, Inc., founded in 2020, serving as Director from 2020 to 2022.
Current jobs include Chairman & Chief Executive Officer at Rythera Therapeutics, Inc. since 2020, Director at Galderma Holding SA, and Independent Director at Galderma Group AG since 2022.
Former jobs include President & Chief Executive Officer at Neomend, Inc. from 2001 to 2003, President & Chief Executive Officer at Prograft Medical, Inc. from 1997 to 2000, and Business Leader at W.
L.
Gore & Associates, Inc. Education includes undergraduate studies at the University of Hawai'i at Hilo and an MBA from Pepperdine Graziadio Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
0%
31/12/2025 3 588 ( 0% ) 817 992 $ 30/06/2026

Postes actifs de L. Browne

SociétésPosteDébut
Directeur/Membre du Conseil -
Directeur Général -

Anciens postes connus de L. Browne

SociétésPosteFin
Fondateur 01/05/2022
REVANCE THERAPEUTICS, INC. Fondateur 14/10/2019
Directeur Général -
Prograft Medical, Inc.
Directeur Général -
Corporate Officer/Principal -
Voir l'expérience en détail de L. Browne

Formation de L. Browne

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

38

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Commercial Services

Consumer Services

Health Technology

Prograft Medical, Inc.

Health Technology

Consumer Services

Technology Services

Commercial Services